Cargando…
Thalidomide results in diminished ovarian reserve in reproductive age female IBD patients
The effectiveness of thalidomide in treating inflammatory bowel disease (IBD) has been widely recognized. Meanwhile, many serious adverse drug reactions have been observed, but no know reports on ovarian reserve function. Female patients, ranging in age between 18 and 40, were referred to our instit...
Autores principales: | Peng, Xiang, Zhi, Min, Wei, Ming, Li, Ting-Ting, Zhang, Min, Zhang, Yuan-Qi, He, Huan, Su, Mingli, Wang, Wei, Chen, Jun-rong, Tang, Jian, Gao, Xiang, Hu, Pin-Jin, Liang, Xiao-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457844/ https://www.ncbi.nlm.nih.gov/pubmed/28538364 http://dx.doi.org/10.1097/MD.0000000000006540 |
Ejemplares similares
-
Thalidomide for inflammatory bowel disease: Systematic review
por: Bramuzzo, Matteo, et al.
Publicado: (2016) -
Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide
por: Chen, Haiying, et al.
Publicado: (2016) -
Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence: Case report and literature review
por: Hu, Huiqin, et al.
Publicado: (2016) -
Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2022) -
Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis
por: Guo, Lin, et al.
Publicado: (2023)